CSHL Professor David Tuveson and Research Investigator Claudia Tonelli have found a way to “intercept” pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to prevent pancreatic cancer from forming in the first place.

A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and mechanistic understanding of the RAD52-DNA complex may help researchers develop new anti-cancer drugs.

Nearly 800,000 Americans suffer a stroke each year. Researchers at the University of Nebraska have patented  an innovative, portable treatment device, called the pTACS Somatosensory Biomedical Device, that could significantly reduce mortality and disability caused by strokes.  The device uses micro pulses of air to stimulate the brain and increase blood flow in the cerebral cortex, thus saving brain cells from death. The researchers envision their device being installed in emergency rooms, rehabilitation centers and even ambulances to start treatment when every second counts.